These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 28213071

  • 1. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Miki Y, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K.
    Neurosci Lett; 2017 Apr 03; 645():40-45. PubMed ID: 28213071
    [Abstract] [Full Text] [Related]

  • 2. Alteration of mitochondrial protein PDHA1 in Lewy body disease and PARK14.
    Miki Y, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K.
    Biochem Biophys Res Commun; 2017 Aug 05; 489(4):439-444. PubMed ID: 28564592
    [Abstract] [Full Text] [Related]

  • 3. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.
    Acta Neuropathol; 2002 Sep 05; 104(3):225-30. PubMed ID: 12172907
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
    Chiu CC, Lu CS, Weng YH, Chen YL, Huang YZ, Chen RS, Cheng YC, Huang YC, Liu YC, Lai SC, Lin KJ, Lin YW, Chen YJ, Chen CL, Yeh TH, Wang HL.
    Mol Neurobiol; 2019 Jun 05; 56(6):3835-3853. PubMed ID: 30088174
    [Abstract] [Full Text] [Related]

  • 6. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S.
    J Neurol Neurosurg Psychiatry; 2000 May 05; 68(5):605-8. PubMed ID: 10766891
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
    Tanji K, Miki Y, Mori F, Kon T, Kakita A, Takahashi H, Wakabayashi K.
    Brain Pathol; 2019 Nov 05; 29(6):803-812. PubMed ID: 31006160
    [Abstract] [Full Text] [Related]

  • 8. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y, Ayaki T, Horibe T, Ito H, Takahashi R, Kawakami K.
    Brain Res; 2018 Feb 01; 1680():39-45. PubMed ID: 29246765
    [Abstract] [Full Text] [Related]

  • 9. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 01; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 10. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M, Gelpi E, Martí MJ, Compta Y.
    Neuropathol Appl Neurobiol; 2016 Aug 01; 42(5):451-62. PubMed ID: 26810462
    [Abstract] [Full Text] [Related]

  • 11. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T.
    Am J Pathol; 1998 Apr 01; 152(4):879-84. PubMed ID: 9546347
    [Abstract] [Full Text] [Related]

  • 12. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K.
    Neurosci Lett; 1999 May 14; 266(3):213-6. PubMed ID: 10465711
    [Abstract] [Full Text] [Related]

  • 13. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.
    Lancet Neurol; 2011 Mar 14; 10(3):230-40. PubMed ID: 21317042
    [Abstract] [Full Text] [Related]

  • 14. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM, Holton JL, Revesz T, Dickson DW.
    Acta Neuropathol; 2011 Aug 14; 122(2):187-204. PubMed ID: 21720849
    [Abstract] [Full Text] [Related]

  • 15. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS.
    Am J Pathol; 2002 May 14; 160(5):1655-67. PubMed ID: 12000718
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY, El-Agnaf OMA.
    Neuropathol Appl Neurobiol; 2019 Oct 14; 45(6):597-608. PubMed ID: 30422353
    [Abstract] [Full Text] [Related]

  • 17. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W, Bousset L, Baekelandt V, Melki R.
    Cell Tissue Res; 2018 Jul 14; 373(1):195-212. PubMed ID: 29704213
    [Abstract] [Full Text] [Related]

  • 18. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC.
    Neurobiol Aging; 2005 Jul 14; 26(8):1183-92. PubMed ID: 15917102
    [Abstract] [Full Text] [Related]

  • 19. Involvement of autophagic protein DEF8 in Lewy bodies.
    Tanaka MT, Miki Y, Bettencourt C, Ozaki T, Tanji K, Mori F, Kakita A, Wakabayashi K.
    Biochem Biophys Res Commun; 2022 Oct 01; 623():170-175. PubMed ID: 35921708
    [Abstract] [Full Text] [Related]

  • 20. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H, Iseki E, Tsuchiya K, Togo T, Katsuse O, Uéda K, Kato M, Kosaka K.
    Clin Neuropathol; 2002 Oct 01; 21(6):269-77. PubMed ID: 12489676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.